Read More 1 minute read Growth News News Bristol Myers Squibb Partners with Cellares in $380M CAR T Cell Therapy Deal Key Highlights Worldwide agreement worth up to $380M includes capacity reservation and supply for CAR T cell therapies. Cellares… byChris-Anne RoqueApril 23, 2024